Cargando…
Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
Acute respiratory distress syndrome (ARDS) related to SARS-CoV-2 infection has some unusual characteristics that differentiate it from the pathophysiology described in the more ‘typical’ ARDS. Among multiple hypotheses, a close similarity has been suggested between COVID-19 ARDS and neonatal respira...
Autores principales: | Bhatt, Reena M, Clark, Howard W, Girardis, Massimo, Busani, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441217/ https://www.ncbi.nlm.nih.gov/pubmed/34521648 http://dx.doi.org/10.1136/bmjresp-2020-000867 |
Ejemplares similares
-
RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS
por: Bhandari, Vineet, et al.
Publicado: (2023) -
Techniques to evaluate surfactant activity for a personalized therapy of RDS neonates
por: Autilio, Chiara
Publicado: (2021) -
Estimation of early life endogenous surfactant pool and CPAP failure in preterm neonates with RDS
por: Raschetti, Roberto, et al.
Publicado: (2019) -
Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020) -
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?
por: Blum, Kenneth, et al.
Publicado: (2022)